The Short Peripheral Intravenous Catheters Market size was valued at USD 2.50 Billion in 2022 and is projected to reach USD 4.00 Billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030.
The Short Peripheral Intravenous Catheters (SPIVCs) market is broadly categorized by application, with significant focus on hospitals, clinics, ambulatory surgical centers (ASCs), and other healthcare facilities. Hospitals are the largest end-users of SPIVCs due to their high patient influx, diverse medical conditions, and intensive care requirements. In hospitals, these catheters are commonly used for administering medications, fluids, and blood products, as well as for collecting blood samples. The versatility and ease of insertion of SPIVCs make them ideal for inpatient care, where frequent intravenous access is needed. They are utilized across various departments, including emergency, oncology, cardiology, and pediatrics. The growing demand for these catheters in hospitals is driven by the increasing patient population, the rise of chronic diseases, and the need for advanced healthcare infrastructure globally.
In addition to their use in hospitals, SPIVCs are also widely used in clinics, where the patient volume is relatively lower, but their demand remains substantial. Clinics often use these catheters for routine intravenous therapies, such as fluid replacement, antibiotics administration, and minor surgical procedures. They are particularly beneficial in outpatient settings for quick, less-invasive procedures that require minimal monitoring. The rising number of outpatient clinics, particularly those focusing on chronic disease management, is expected to drive the demand for SPIVCs in this segment. As healthcare systems shift towards outpatient care to reduce hospital stays and healthcare costs, the demand for SPIVCs in clinics is poised to grow significantly.
Hospitals are the primary segment for the adoption of Short Peripheral Intravenous Catheters (SPIVCs), driven by the necessity for intravenous access in various treatment scenarios. With high volumes of patients, including those in critical and emergency care, hospitals require reliable and effective catheter solutions for drug delivery, hydration, and other essential medical services. SPIVCs are commonly used for a variety of medical interventions, including post-operative care, cancer treatments, and intravenous nutrition. The demand for SPIVCs in hospitals is also bolstered by the rising incidence of conditions such as cardiovascular diseases, diabetes, and cancer, which require long-term intravenous therapy. Moreover, advancements in catheter design, such as the development of safer, more comfortable, and more efficient catheters, are contributing to the increased adoption of SPIVCs in hospital settings.
The growing prevalence of chronic diseases and the aging population are major factors driving the hospital segment of the market. In addition to these, technological innovations that improve the performance of SPIVCs, such as catheters with enhanced safety features, are also contributing to their increasing use. The integration of SPIVCs in various departments within hospitals, including intensive care units (ICUs), emergency departments (EDs), and outpatient care units, further underscores their critical role in patient care. Hospitals are investing in advanced medical equipment and disposables to maintain a high standard of care, which includes adopting newer and more efficient catheters. This expansion and improvement in healthcare infrastructure will continue to drive demand for SPIVCs in hospitals worldwide.
Clinics are increasingly adopting Short Peripheral Intravenous Catheters (SPIVCs) to cater to patients requiring less intensive, but regular intravenous access. These settings, which often focus on outpatient care and specialized treatments, utilize SPIVCs for a variety of functions such as administering fluids, antibiotics, and blood products, or managing conditions like dehydration. As outpatient services become more prevalent, especially for routine treatments, the use of SPIVCs in clinics is growing. Clinics providing services in cardiology, oncology, nephrology, and diabetes management often rely on SPIVCs to deliver intravenous therapies efficiently. Additionally, the demand for minimally invasive treatments in outpatient clinics, as opposed to prolonged hospital admissions, is helping to accelerate the adoption of SPIVCs in this segment.
Furthermore, the rise in ambulatory care centers and the push toward cost-effective healthcare services are supporting the growth of the SPIVC market in clinics. Clinics offer more streamlined and focused services, which makes them an ideal environment for the use of SPIVCs, especially in procedures like blood draws, minor surgeries, and intravenous drug administration. As more clinics focus on providing accessible and cost-efficient care, they require reliable and user-friendly intravenous solutions, leading to an increased adoption of SPIVCs. The trend toward decentralizing healthcare from hospitals to clinics is expected to continue, further increasing the market share of SPIVCs in outpatient and specialty care settings.
Ambulatory Surgical Centers (ASCs) represent a significant and growing segment in the Short Peripheral Intravenous Catheters (SPIVCs) market. ASCs typically perform outpatient surgeries and medical procedures that require short recovery times, making the use of SPIVCs critical for administering anesthesia, fluids, and medications during and after surgical procedures. The need for rapid, effective intravenous access in these settings ensures that SPIVCs are a core part of their medical supplies. As surgical procedures shift from inpatient settings to ASCs due to cost efficiencies, the demand for SPIVCs continues to rise in this segment. These catheters are preferred for their ease of insertion, patient comfort, and ability to provide reliable access during short-duration procedures.
With the expansion of ASCs, particularly in developing regions, the need for SPIVCs is expected to increase as the number of surgeries and minimally invasive procedures performed in outpatient settings rises. The growing preference for same-day discharge and the rising focus on reducing healthcare costs are key drivers behind the increased adoption of SPIVCs in ASCs. As ASCs specialize in specific treatments such as orthopedic, gastrointestinal, and ophthalmic surgeries, the requirement for advanced intravenous access methods like SPIVCs will continue to rise, further contributing to the market's expansion. In addition, the increasing trend of patient convenience and the rise in the use of robotic-assisted surgeries in outpatient centers are expected to further boost the demand for these catheters.
The "Other" segment in the Short Peripheral Intravenous Catheters (SPIVCs) market includes a diverse range of healthcare facilities such as nursing homes, rehabilitation centers, and home healthcare environments. In these settings, SPIVCs are utilized to administer fluids, medications, and blood products, often for patients who require long-term care but do not need hospitalization. In nursing homes, SPIVCs are used for elderly patients who may require intravenous therapy for hydration, antibiotic treatments, or blood transfusions. As the elderly population grows globally, the need for intravenous solutions in long-term care facilities is expected to drive demand for SPIVCs. Rehabilitation centers also use SPIVCs to manage patients recovering from surgeries or trauma, requiring intravenous access for fluid and medication administration.
Moreover, the increasing trend of home healthcare, where patients receive medical care in the comfort of their own homes, is expected to contribute to the growth of SPIVCs in "Other" healthcare settings. Home healthcare services, especially for chronic disease management and post-surgical care, often rely on SPIVCs for the safe and effective delivery of intravenous treatments. As healthcare systems worldwide push for more home-based care solutions, the demand for SPIVCs in non-hospital and non-clinic settings will likely increase, opening new growth opportunities for the market. The shift toward personalized and community-based healthcare further emphasizes the role of SPIVCs in delivering essential intravenous therapies outside of traditional healthcare institutions.
Download In depth Research Report of Short Peripheral Intravenous Catheters Market
By combining cutting-edge technology with conventional knowledge, the Short Peripheral Intravenous Catheters market is well known for its creative approach. Major participants prioritize high production standards, frequently highlighting energy efficiency and sustainability. Through innovative research, strategic alliances, and ongoing product development, these businesses control both domestic and foreign markets. Prominent manufacturers ensure regulatory compliance while giving priority to changing trends and customer requests. Their competitive advantage is frequently preserved by significant R&D expenditures and a strong emphasis on selling high-end goods worldwide.
BD Medical
C.R. Bard
Smiths Medical
B. Braun Melsungen
Terumo Medical
Retractable Technologies
NIPRO Medical
Hospira
GaltNeedleTech
Teleflex
Vygon
Medline Industries
Dukwoo Medical
Vigmed
MVM Life Science Partners
Shanghai Puyi Medical Instruments
North America (United States, Canada, and Mexico, etc.)
Asia-Pacific (China, India, Japan, South Korea, and Australia, etc.)
Europe (Germany, United Kingdom, France, Italy, and Spain, etc.)
Latin America (Brazil, Argentina, and Colombia, etc.)
Middle East & Africa (Saudi Arabia, UAE, South Africa, and Egypt, etc.)
For More Information or Query, Visit @ Short Peripheral Intravenous Catheters Market Size And Forecast 2024-2030
Key trends in the Short Peripheral Intravenous Catheters (SPIVCs) market include the development of safer and more advanced catheter technologies, such as catheters designed to reduce the risk of infections and enhance patient comfort. The adoption of new materials that prevent thrombosis, reduce irritation, and increase the longevity of the catheters is gaining traction. Additionally, the market is witnessing a shift toward integrated solutions, where SPIVCs are part of a broader intravenous therapy management system, enhancing ease of use and reducing potential complications. Another key trend is the increasing preference for catheter types that offer improved patient safety, such as those equipped with safety features like automatic retractable needles to prevent needle-stick injuries.
Opportunities in the SPIVCs market are vast due to the ongoing shift in healthcare delivery models. As hospitals, clinics, and ASCs prioritize cost-effective, minimally invasive treatments, the demand for SPIVCs is expected to grow. Moreover, the rising prevalence of chronic diseases and the aging population, especially in developed countries, will drive the need for more intravenous therapies across various healthcare settings. Emerging markets in Asia-Pacific and Latin America offer untapped growth potential, where the healthcare infrastructure is expanding and healthcare providers are increasingly relying on modern intravenous solutions. Additionally, the increasing trend toward home healthcare presents a significant opportunity for the SPIVCs market, as patients requiring long-term intravenous care are treated in non-hospital settings.
What are Short Peripheral Intravenous Catheters (SPIVCs)?
SPIVCs are medical devices used for providing intravenous access to patients for fluid and medication administration. They are inserted into veins, usually in the arm or hand.
How are SPIVCs used in hospitals?
SPIVCs are widely used in hospitals for administering medications, fluids, and blood products, especially in emergency, intensive care, and surgical departments.
What are the advantages of using SPIVCs?
The main advantages of SPIVCs include ease of insertion, minimal discomfort, and the ability to provide reliable intravenous access for various medical procedures.
What factors are driving the growth of the SPIVCs market?
The growing prevalence of chronic diseases, aging population, and increasing demand for outpatient care are the major factors driving market growth.
Are there any safety concerns associated with SPIVCs?
While SPIVCs are generally safe, issues such as catheter-related infections, vein irritation, and accidental needle-stick injuries can occur if not managed properly.
How do SPIVCs compare to other types of intravenous catheters?
SPIVCs are typically used for short-term access and are preferred for their ease of insertion and comfort, compared to longer-term catheters like central venous catheters.
What are the key trends in the SPIVCs market?
Key trends include advancements in catheter safety features, the development of materials that reduce complications, and the integration of SPIVCs into broader intravenous therapy systems.
Which healthcare settings use SPIVCs the most?
Hospitals, clinics, and ambulatory surgical centers (ASCs) are the primary healthcare settings where SPIVCs are used extensively.
What are the future opportunities in the SPIVCs market?
Opportunities lie in emerging markets, the growth of home healthcare services, and the development of safer, more efficient catheters with advanced features.
How are advancements in SPIVC technology impacting the market?
Advancements in SPIVC technology, such as safer, more comfortable designs, and the use of advanced materials, are driving increased adoption and improving patient outcomes.